Gilead Sciences Inc (NASDAQ:GILD)

67.75
BATS BZX Real-Time Price
As of 11:42am ET
 -0.27 / -0.40%
Today’s Change
63.76
Today|||52-Week Range
89.54
-5.43%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$87.2B

Company Description

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. It also offers other pharmaceutical products under the Letairis, Ranexa, AmBisome, and Zydelig brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Contact Information

Gilead Sciences, Inc.
333 Lakeside Drive
Foster City California 94404
P:(650) 574-3000
Investor Relations:
(650) 524-7792

Employees

Shareholders

Mutual fund holders45.16%
Other institutional36.14%
Individual stakeholders1.20%

Top Executives

John F. MilliganPresident, Chief Executive Officer & Director
Robin L. WashingtonCFO, Principal Accounting Officer & Executive VP
Andrew ChengChief Medical Officer & Executive Vice President
John G. McHutchisonCSO, Head-Research & Development
Brett A. PletcherSecretary, Chief Compliance Officer & Executive VP